10 employees
Kiwi biosciences is a biotech company that develops enzymes to make food for patients who suffer from Irritable Bowel Syndrome (IBS).
2020
Kiwi Biosciences raised undisclosed on August 30, 2021
Investors: Y Combinator and Acacia Venture Capital Partners